Influenza A Virus H1N1 Antikörper (Influenza A Virus)
(1 reference)-
- Target
- Influenza A Virus H1N1
-
Reaktivität
- Influenza A Virus
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Haemagglutination (H)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Isotyp
- IgG
-
anti-Influenza A Virus H1N1 antibody (AA 18-344)
Reaktivität: Influenza A Virus H1N1 WB, EIA Wirt: Maus Monoclonal AT1G7 unconjugated
anti-Influenza A Virus H1N1 antibody (Influenza Virus) (AA 35-48)Reaktivität: Influenza Virus WB Wirt: Kaninchen Polyclonal unconjugated
anti-Influenza A Virus H1N1 antibody (Influenza Virus) (AA 238-253)Reaktivität: Influenza Virus WB Wirt: Kaninchen Polyclonal unconjugated
anti-Influenza A Virus H1N1 antibodyReaktivität: Influenza A Virus H1N1 EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
: "Interaction of influenza A virus matrix protein with RACK1 is required for virus release." in: Cellular microbiology, Vol. 14, Issue 5, pp. 774-89, (2012) (PubMed).
-
: "Interaction of influenza A virus matrix protein with RACK1 is required for virus release." in: Cellular microbiology, Vol. 14, Issue 5, pp. 774-89, (2012) (PubMed).
-
- Target
- Influenza A Virus H1N1
- Andere Bezeichnung
- INFLUENZA A H1N1
- Substanzklasse
- Influenza Virus
-
